Glaxosmithkline Pharmaceuticals Ltd - Stock Price

As on19 Oct 2021 10:54 AM
  • NSE : GLAXO
  • BSE : 500660
  • ISIN CODE : INE159A01016
  • Industry : Pharmaceuticals & Drugs
  • House : Glaxosmithkline - MNC
Glaxosmithkline Pharmaceuticals Ltd is not traded on BSE/NSE
1473.55
-0.08 %-1.25
Previous Close 1474.80
Day's Open 1487.00
Bid Price (Qty) 1472.85 (5)
Offer Price (Qty) 1473.80 (1)
Day’s High - Low 1487.00 - 1469.70
52 Week Range 1376 - 1767.4
Volume Traded (in 000's) 10.31
Value traded (in Cr.) 1.52
PE Ratio (x) 68.05
M Cap (in Cr.)24974.68

Glaxosmithkline Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 24974.68
Earning Per Share (EPS TTM) (Rs.) 21.66
Price To Earnings (P/E) Ratio 68.05
Book Value Per Share (Rs.) 79.50
Price/Book (MRQ) 18.54
Price/Earning (TTM) 56.48
ROCE (%) 32.95
PAT Margin 11.20
Dividend Yield 2.03
Face Value 10

Financial Summary

Parameter MAR 21 (`Mn.) MAR 20 (`Mn.) YoY %Change
Balance Sheet :
Share Capital1694.061694.060.00
Total Non-Current Liabilities1786.811801.93-0.84
Total Current Liabilities13324.7410219.5030.39
Total Liabilities30102.3530227.48-0.41
Total Non-Current Assets8075.8012478.66-35.28
Currents Investments0.000.000.00
Cash and Bank11579.7910832.036.90
Total Current Assets22026.5417748.8124.10
Total Assets30102.3530227.48-0.41
Profit & Loss :
Gross Sales31988.6032243.80-0.79
Net Sales31988.6032243.80-0.79
Total Expenditure25035.3025671.30-2.48
Operating Profit8059.107362.609.46
Profit After Tax3581.50932.00284.28
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Share Holdings

Description Percent of Share (%)
Promoters75
Non-Institution12.45
Mutual Funds/Uti4.06
Fi/Banks/Insurance1.44
FII0
Government0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: R S Karnad
  • Managing Director: S Venkatesh
  • Secretary: Ajay Nadkarni

Registered Office

Address : Dr Annie Besant Road,Worli, Mumbai,
Maharashtra-400030
Tel : 022-24959595 Fax : 022-24959494 Email : askus@gsk.com Website : www.gsk-india.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1472.95. Its current market capitalisation stands at Rs 24974.68 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31937.36 Cr and Total Income of Rs.33039.24 Cr. The company's management includes Mark Dawson, Ajay Nadkarni, S Williams, P Thakur, D Sundaram, A N Roy, S Maheshwari, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

Latest News

close